Literature DB >> 23270206

Antioxidant and antiradical properties of esculin, and its effect in a model of epirubicin-induced bone marrow toxicity.

Sefedin Biljali1, Vera A Hadjimitova, Margarita N Topashka-Ancheva, Denitsa B Momekova, Trayko T Traykov, Margarita H Karaivanova.   

Abstract

AIM: To evaluate the effect of esculin, a plant coumarin glucoside, on free radicals and against epirubicin-induced toxicity on bone marrow cells.
MATERIALS AND METHODS: Antioxidant activity was assessed by a luminol-dependent chemiluminescence method or NBT test in a xanthine-xanthine oxidase system, and two iron-dependent lipid peroxidation systems. In vivo experiments were carried out in epirubicin-treated mice, alone or in a combination with esculin. Genotoxicity of the anthracycline drug was assessed by cytogenetic analysis and an autoradiographic assay.
RESULTS: Esculin inactivated superoxide anion radicals in both systems we used. It exerted SOD-mimetic effect and reduced the level of superoxide radicals generated in a xanthine-xanthine oxidase system by 30%. Esculin also showed an antioxidant effect in a model of Fe2+-induced lipid peroxidation. Cytogenetic analysis showed that epirubicin had a marked influence on the structure of metaphase chromosomes of normal bone marrow cells. Inclusion of esculin in the treatment protocol failed to ameliorate the epirubicin-induced antiproliferative effects and genotoxicity in bone marrow cells.
CONCLUSION: In this study the ability of the coumarin glucoside esculin to scavenge superoxide radicals and to decrease Fe-induced lipid peroxidation was documented. However, despite the registered antioxidant effects the tested compound failed to exert cytoprotection in models of anthracycline-induced genotoxicity in bone marrow cells. The results of this study warrant for more precise further evaluation of esculin, employing different test systems and end-points and a wider range of doses to more precisely appraise its potential role as a chemoprotective/resque agent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270206     DOI: 10.2478/v10153-011-0096-4

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  4 in total

1.  Protective effect of esculin against prooxidant aflatoxin B1-induced nephrotoxicity in mice.

Authors:  Farah Naaz; M Z Abdin; Saleem Javed
Journal:  Mycotoxin Res       Date:  2013-12-11       Impact factor: 3.833

2.  Evaluation of Hymenodictyon excelsum Phytochemical's Therapeutic Value Against Prostate Cancer by Molecular Docking Study.

Authors:  Mohammad Mijanur Rahman
Journal:  Jundishapur J Nat Pharm Prod       Date:  2015-02-20

3.  In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation.

Authors:  Rok Martinčič; Janez Mravljak; Urban Švajger; Andrej Perdih; Marko Anderluh; Marjana Novič
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

4.  Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway.

Authors:  Xi-Ding Yang; Zhuo Chen; Ling Ye; Jing Chen; Yong-Yu Yang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.